
|Articles|June 1, 2019
- Pharmaceutical Executive-06-01-2019
- Volume 39
- Issue 6
Pharmaceutical Executive, June 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive June 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 6 years ago
Pharm Exec's Top 50 Companies 2019over 6 years ago
The Argument for External Comparator Adoptionover 6 years ago
Pharma Medical Affairs: A Blueprint for Futureover 6 years ago
'Vision’ Quest: Leading Through Changealmost 7 years ago
Pharm Exec 50 Hints to Rest of ’19almost 7 years ago
Predicting the Future of European Health Policyalmost 7 years ago
A Critical Juncture for Antibiotic R&Dalmost 7 years ago
New Strategies Sought to Pay for Costly Curesalmost 7 years ago
Site Payments: Drilling in on Forecast, Budget Issuesalmost 7 years ago
Building the Startup Dream TeamNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Icotyde as Treatment of Moderate-to-Severe Plaque Psoriasis in Adults and Adolescents
2
What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them
3
What Governance Resets Should Pharma Companies Take in Response to AI?
4
Conflict in Middle East Disrupts Pharma Drug Supplies: Report
5




